Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Treatment of aggression with topiramate in male borderline patients: a double-blind, placebo-controlled study.

Nickel MK, Nickel C, Kaplan P, Lahmann C, Mühlbacher M, Tritt K, Krawczyk J, Leiberich PK, Rother WK, Loew TH.

Biol Psychiatry. 2005 Mar 1;57(5):495-9.

PMID:
15737664
2.

Treatment of aggression with topiramate in male borderline patients, part II: 18-month follow-up.

Nickel MK, Loew TH.

Eur Psychiatry. 2008 Mar;23(2):115-7. Epub 2007 Nov 19.

PMID:
18024088
3.

Topiramate treatment of aggression in female borderline personality disorder patients: a double-blind, placebo-controlled study.

Nickel MK, Nickel C, Mitterlehner FO, Tritt K, Lahmann C, Leiberich PK, Rother WK, Loew TH.

J Clin Psychiatry. 2004 Nov;65(11):1515-9.

PMID:
15554765
4.

Lamotrigine treatment of aggression in female borderline-patients: a randomized, double-blind, placebo-controlled study.

Tritt K, Nickel C, Lahmann C, Leiberich PK, Rother WK, Loew TH, Nickel MK.

J Psychopharmacol. 2005 May;19(3):287-91.

PMID:
15888514
5.

Topiramate in treatment of depressive and anger symptoms in female depressive patients: a randomized, double-blind, placebo-controlled study.

Nickel C, Lahmann C, Tritt K, Muehlbacher M, Kaplan P, Kettler C, Krawczyk J, Loew TH, Rother WK, Nickel MK.

J Affect Disord. 2005 Aug;87(2-3):243-52.

PMID:
15985295
6.

Topiramate in treatment of patients with chronic low back pain: a randomized, double-blind, placebo-controlled study.

Muehlbacher M, Nickel MK, Kettler C, Tritt K, Lahmann C, Leiberich PK, Nickel C, Krawczyk J, Mitterlehner FO, Rother WK, Loew TH, Kaplan P.

Clin J Pain. 2006 Jul-Aug;22(6):526-31.

PMID:
16788338
7.

Topiramate treatment for women with borderline personality disorder: a double-blind, placebo-controlled study.

Loew TH, Nickel MK, Muehlbacher M, Kaplan P, Nickel C, Kettler C, Fartacek R, Lahmann C, Buschmann W, Tritt K, Bachler E, Mitterlehner F, Pedrosa Gil F, Leiberich P, Rother WK, Egger C.

J Clin Psychopharmacol. 2006 Feb;26(1):61-6.

PMID:
16415708
8.

Aripiprazole in the treatment of patients with borderline personality disorder: a double-blind, placebo-controlled study.

Nickel MK, Muehlbacher M, Nickel C, Kettler C, Pedrosa Gil F, Bachler E, Buschmann W, Rother N, Fartacek R, Egger C, Anvar J, Rother WK, Loew TH, Kaplan P.

Am J Psychiatry. 2006 May;163(5):833-8.

PMID:
16648324
9.

Lamotrigine treatment of aggression in female borderline patients, Part II: an 18-month follow-up.

Leiberich P, Nickel MK, Tritt K, Pedrosa Gil F.

J Psychopharmacol. 2008 Sep;22(7):805-8. doi: 10.1177/0269881107084004. Epub 2008 Feb 28.

PMID:
18308777
10.

Topiramate reduced aggression in female patients with borderline personality disorder.

Nickel M.

Eur Arch Psychiatry Clin Neurosci. 2007 Oct;257(7):432-3. No abstract available.

PMID:
17902007
12.

Impact of trait impulsivity and state aggression on divalproex versus placebo response in borderline personality disorder.

Hollander E, Swann AC, Coccaro EF, Jiang P, Smith TB.

Am J Psychiatry. 2005 Mar;162(3):621-4.

PMID:
15741486
13.

Topiramate augmentation in patients with resistant major depressive disorder: a double-blind placebo-controlled clinical trial.

Mowla A, Kardeh E.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Jun 1;35(4):970-3. doi: 10.1016/j.pnpbp.2011.01.016. Epub 2011 Feb 1.

PMID:
21291943
14.

A placebo-controlled, random-assignment, parallel-group pilot study of adjunctive topiramate for patients with schizoaffective disorder, bipolar type.

Roy Chengappa K, Kupfer DJ, Parepally H, John V, Basu R, Buttenfield J, Schlicht P, Houck P, Brar JS, Gershon S.

Bipolar Disord. 2007 Sep;9(6):609-17.

PMID:
17845276
15.

A preliminary study of lamotrigine in the treatment of affective instability in borderline personality disorder.

Reich DB, Zanarini MC, Bieri KA.

Int Clin Psychopharmacol. 2009 Sep;24(5):270-5. doi: 10.1097/YIC.0b013e32832d6c2f.

PMID:
19636254
16.

The impact of migraine prevention on daily activities: a longitudinal and responder analysis from three topiramate placebo-controlled clinical trials.

Dahlöf C, Loder E, Diamond M, Rupnow M, Papadopoulos G, Mao L.

Health Qual Life Outcomes. 2007 Oct 4;5:56.

17.

A preliminary double-blind, placebo-controlled trial of divalproex sodium in borderline personality disorder.

Hollander E, Allen A, Lopez RP, Bienstock CA, Grossman R, Siever LJ, Merkatz L, Stein DJ.

J Clin Psychiatry. 2001 Mar;62(3):199-203.

PMID:
11305707
18.

Topiramate versus bupropion SR when added to mood stabilizer therapy for the depressive phase of bipolar disorder: a preliminary single-blind study.

McIntyre RS, Mancini DA, McCann S, Srinivasan J, Sagman D, Kennedy SH.

Bipolar Disord. 2002 Jun;4(3):207-13.

PMID:
12180276
19.

Double-blind, placebo-controlled trial of topiramate augmentation in treatment-resistant obsessive-compulsive disorder.

Berlin HA, Koran LM, Jenike MA, Shapira NA, Chaplin W, Pallanti S, Hollander E.

J Clin Psychiatry. 2011 May;72(5):716-21. doi: 10.4088/JCP.09m05266gre. Epub 2010 Aug 10.

PMID:
20816027
20.

Topiramate treatment of aggression in male borderline patients.

Nickel MK.

Aust N Z J Psychiatry. 2007 May;41(5):461-2. No abstract available.

PMID:
17464743

Supplemental Content

Support Center